Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase II study assessing the efficacy and safety of Inavolisib in combination with ribociclib and fulvestrant versus placebo combination in advanced breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Inavolisib (Inavolisib)
• KISQALI (ribociclib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING